Infliximab-associated focal segmental glomerulosclerosis in a patient with ankylosing spondylitis

[1]  Mika Watanabe,et al.  Infliximab-Induced Tubulointerstitial Nephritis with Image Findings of Striated Nephrogram in Crohn's Disease. , 2018, The Tohoku journal of experimental medicine.

[2]  C. Cortese,et al.  Behçet's syndrome and focal segmental glomerulosclerosis with nephrotic syndrome - successful treatment with etanercept
. , 2018, Clinical nephrology.

[3]  B. Bonnotte,et al.  Biological treatments in giant cell arteritis & Takayasu arteritis. , 2017, European journal of internal medicine.

[4]  N. Miyasaka,et al.  Acute Tubulointerstitial Nephritis Associated with Infliximab in a Patient with Crohn's Disease. , 2016, Internal medicine.

[5]  K. Dahan,et al.  Nephrotic syndrome after infliximab treatment in a patient with ulcerative colitis. , 2015, Journal of gastrointestinal and liver diseases : JGLD.

[6]  G. Mourad,et al.  Psoriasis‐associated IgA nephropathy under infliximab therapy , 2015, International journal of dermatology.

[7]  A. Mathieu,et al.  Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort. , 2014, Autoimmunity Reviews.

[8]  N. Won,et al.  A case of late onset-acute tubulointerstitial nephritis with infliximab and mesalazine treatment in a patient with Crohn's disease. , 2014, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi.

[9]  I. Iwanicki-Caron,et al.  Acute renal artery occlusion following infliximab infusion. , 2013, World journal of nephrology.

[10]  Eun Jung Lee,et al.  Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-a blocker , 2013, Rheumatology International.

[11]  G. Navis,et al.  Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis , 2012, PloS one.

[12]  J. Prinz.  Autoimmune-like syndromes during TNF blockade: does infection have a role? , 2011, Nature Reviews Rheumatology.

[13]  G. Laverman,et al.  Time for a comeback of NSAIDs in proteinuric chronic kidney disease? , 2010, Netherlands Journal of Medicine.

[14]  X. Mariette,et al.  IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  K. Chayama,et al.  Infliximab treatment for Crohn’s disease in a patient with IgA nephropathy , 2009, Clinical journal of gastroenterology.

[16]  M. Ramos-Casals,et al.  A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases , 2008, Medicine.

[17]  M. Khamashta,et al.  Autoimmune diseases induced by TNF-targeted therapies. , 2008, Best practice & research. Clinical rheumatology.

[18]  A. Matsuda,et al.  Renal amyloidosis associated with extracapillary glomerulonephritis and vasculitis in a patient with inflammatory bowel disease treated with infliximab. , 2008, Clinical nephrology.

[19]  G. Luxton,et al.  Infliximab and nephrotic syndrome. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  E. Fritschka,et al.  Renal diseases in ankylosing spondylitis: Review of the literature illustrated by case reports , 2005, Clinical Rheumatology.

[21]  Mukut Sharma,et al.  Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. , 2002, Kidney international.

[22]  R. Cattell,et al.  Infliximab treatment for Crohn's disease , 2001, Postgraduate medical journal.

[23]  D. Isenberg,et al.  Renal abnormalities in ankylosing spondylitis. , 1987, British journal of rheumatology.

[24]  G. Lagrue,et al.  Diclofenac, a nonsteroidal anti-inflammatory drug, decreases proteinuria in some glomerular diseases: a controlled study. , 1987, American journal of nephrology.